GSK plc vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
6.3
Neutral
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
GSK
High-quality business with 41% return on equity and 18% profit margins.
⚠ cautious analyst consensus — few Buy ratings.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $57.65 (+11.7%)
8 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
GSK
PFE
13.4×
Trailing P/E
19.4×
9.9×
Forward P/E
9.4×
17.8%
Profit Margin
12.4%
72.9%
Gross Margin
75.8%
40.9%
ROE
8.9%
1.5%
Revenue Growth
-1.2%
8.4%
Earnings Growth
—
0.35
Beta
0.39
—
Price / Book
—
$103.0B
Market Cap
$149.8B
$35 – $62
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →